Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132303) titled 'Survey on treatment practice of von Hippel-Lindau Disease in China' on Sept. 11.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Peking University First Hospital

Condition: von Hippel-Lindau disease

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-11

Target Sample Size: Research group(Physicians,Patients):162;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=339579

Published by HT Digital Content Services with permission from Health Daily Digest....